Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04567706 · ClinicalTrials.gov registry record
A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma
A clinical trial of Melanoma, sponsored by Ohio State University Comprehensive Cancer Center.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT04567706 is a study of Melanoma that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 1,000 participants, above the 703-participant average among 266 other Melanoma trials with a reported enrollment target (42% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04567706, a study of Melanoma, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study collects and stores blood and tumor samples from patients with malignant melanoma and healthy individuals. The purpose of this study is to gain a better understanding of the causes of melanoma and how melanoma tumors behave. Storing blood and tumor samples for future research may lead to new discoveries that may ultimately help with diagnosing or treating this disease.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
Study Locations (1)
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2013-05-07 |
| Est. Completion | 2027-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04567706
The ClinicalTrials.gov registry entry for NCT04567706 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 703-participant average among 266 other Melanoma trials with a reported enrollment target (42% higher). The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Melanoma appearing as the primary indexed condition, and to 1 intervention - of which Biospecimen Collection is the first listed.
NCT04567706 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04567706 about?
NCT04567706 is a clinical study titled "A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma". This study collects and stores blood and tumor samples from patients with malignant melanoma and healthy individuals. The purpose of this study is to gain a better understanding of the causes of melanoma and how melanoma tumors behave. Storing blood and tumor samples for future research may lead to ...
What is the current status of trial NCT04567706?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2013-05-07. Estimated completion is 2027-10-31.
What conditions does trial NCT04567706 study?
This clinical trial studies the following conditions: Melanoma.
What interventions are being tested in trial NCT04567706?
The interventions under investigation include: Biospecimen Collection (PROCEDURE).
Who is sponsoring clinical trial NCT04567706?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04567706 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
RECRUITING · NA
-
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
RECRUITING · Phase 2
-
Dabrafenib and/or Trametinib Rollover Study
RECRUITING · Phase 4
-
Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED
RECRUITING · Phase 2
-
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
RECRUITING · Phase 1
-
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.